NCT05341687View on ClinicalTrials.gov

Prognostic Value of Respiratory System Compliance Under VV-ECMO on 180-day Mortality in COVID-19 ARDS.

CompletedOBSERVATIONAL

Enrollment

122

Participants

Timeline

Start Date

January 3, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

May 1, 2023

Conditions

ArdsMechanical Ventilation Pressure HighExtracorporeal Membrane Oxygenation

Interventions

OTHER

No applicable

Trial Locations (1)

Unknown

CHU Nancy, Nancy

All Listed Sponsors

lead

Central Hospital, Nancy, France

OTHER

NCT05341687 - Prognostic Value of Respiratory System Compliance Under VV-ECMO on 180-day Mortality in COVID-19 ARDS. | Biotech Hunter | Biotech Hunter